Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9780
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Soham D.-
dc.date.accessioned2021-02-12T09:00:47Z-
dc.date.available2021-02-12T09:00:47Z-
dc.date.issued2020-04-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9780-
dc.descriptionGuided by Dr. Tejal Mehtaen_US
dc.description.abstractThe most frequently observed persistent inflammatory disease, which impacts people, is Seborrheic dermatitis; however, a sporadic phase of childhood exists. Seborrheic dermatitis is not necessarily induced. However, a contributing factor was identified to the proliferation of Malassezia organisms. • Up to 5 per cent of the general population were impacted by adult type of seborrheic dermatitis. The disease mostly affects the head, face and periauricular regions and in certain instances often affects the central spine, axillae and genital area. • Pruritus is not always present, particularly with scalp disease, and is fairly normal. Different therapies, including topical corticosteroids, topical anti-fungal drugs, topical inhibitors of calcineurin and a non-steroidal cream, are Essential. This essay discusses the clinical treatment of the adult population of seborrheic dermatitis in the USA. • • Seborrheic dermatitis (SD) has a chronic inflammatory skin disease, with aggravation periods and recovery in adult patients with immunocompetence. In the first 3 or 4 months of childhood, a transient form of SD develops and improves, even though some cases can continue to recur for several months. • There are instances of SD that arise and resolve within the first 3 to the last 4 months of age. Childhood SD can be limited to or more complex with scalp involvementThe SD for adults, which is far more prevalent than SD and tends to influence more males than females and in comparison to dermal lipid levels resulting from development could be present during puberty first of the androgen- driven sebaceous gland and from sebum secretion3 SD is normal after the age of 50. • Individuals with Hiv see a marked rise, with an prevalence of SD occurring between 30 and 80 percent of people. The frequency of SD is significantly greaterResearchers have been able to reproduce SDs seen with strong association in patients with reduced CD4+T and fungal proliferation in an animal SD model. • The rise Of this incidence is possibly linked to T cell lymphopenia and influences numbers of CD4 + cells involved in immune surveillance.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR01024;-
dc.subjectPPR01024en_US
dc.subjectB. Pharm Project Reporten_US
dc.subjectPharmaceuticsen_US
dc.subjectSeborrheic Dermatitisen_US
dc.titleDrug Delivery and Development for the Treatment of Seborrheic Dermatitisen_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR01024.pdfPPR010241.3 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.